Brief: Seres Therapeutics Inc Qtrly EPS $3.76
07/05/2025 12:10
May 7 (Reuters) - Seres Therapeutics Inc MCRB.O: : QTRLY EPS $3.76 Q1 EARNINGS PER SHARE VIEW $-0.54 -- LSEG IBES DATA Source text: ID:nGNX2n26K5 Further company coverage: MCRB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47